JF
IOVA icon

Jump Financial’s Iovance Biotherapeutics IOVA Stock Holding History

Jump Financial’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.44M Buy
825,903
+801,703
+3,313% +$3.05M 0.03% 664
2026
Q1 		$84.9K Buy
24,200
+2,138
+10% +$6.84K ﹤0.01% 1761
2025
Q4 		$60.2K Buy
+22,062
New +$51K ﹤0.01% 1863
2025
Q1 		– Sell
-10,619
Closed -$78.6K – 1802
2024
Q4 		$78.6K Buy
+10,619
New +$98.4K ﹤0.01% 1551
2023
Q4 		– Sell
-26,337
Closed -$120K – 1984
2023
Q3 		$120K Sell
26,337
-16,093
-38% -$105K ﹤0.01% 1648
2023
Q2 		$299K Buy
42,430
+31,403
+285% +$225K 0.01% 1308
2023
Q1 		$67.4K Sell
11,027
-96,052
-90% -$663K ﹤0.01% 1480
2022
Q4 		$684K Sell
107,079
-16,565
-13% -$129K 0.04% 651
2022
Q3 		$1.19M Buy
+123,644
New +$1.43M 0.05% 554

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Jump Financial's IOVA Position: Q2 2026 in Review

Jump Financial increased its Iovance Biotherapeutics (IOVA) stake by 3,313% in Q2 2026, buying an estimated $3.05M and bringing the position to 825,903 shares worth $3.44M. The position accounts for 0.03% of the portfolio, ranked #664.

Jump Financial first reported a position in IOVA in Q3 2022 and has held it in 9 quarters since. 293 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • Jump Financial held 825,903 shares of Iovance Biotherapeutics worth $3.44M as of Q2 2026.
  • Jump Financial bought 801,703 Iovance Biotherapeutics shares in Q2 2026, an estimated $3.05M.
  • Iovance Biotherapeutics made up 0.03% of Jump Financial's portfolio in Q2 2026, its #664 holding.
  • Jump Financial first reported a position in Iovance Biotherapeutics in Q3 2022 and has held it in 9 quarters since.
  • 293 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.